Chapter 29. Structure-Based Drug Design
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 34, 297-306
- https://doi.org/10.1016/s0065-7743(08)60591-6
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Crystal Structure and Functional Analysis of the HERG Potassium Channel N Terminus: A Eukaryotic PAS DomainPublished by Elsevier ,1998
- Recent advances in sialidase inhibitorsExpert Opinion on Therapeutic Patents, 1998
- The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Initial sar studiesBioorganic & Medicinal Chemistry Letters, 1998
- Factor Xa inhibitors by classical and combinatorial chemistryDrug Discovery Today, 1998
- Structure‐Based Design of Potent Beta‐Lactamase InhibitorsPublished by Wiley ,1998
- ‘Flu’ and structure-based drug designStructure, 1997
- Inhibition of cathepsin K - a novel approach to antiresorptive therapyExpert Opinion on Investigational Drugs, 1997
- X-ray Structure of Active Site-inhibited Clotting Factor XaPublished by Elsevier ,1996
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- Use of structural information in drug design: Current Opinion in Structural Biology 1992, 2:202–210Current Opinion in Structural Biology, 1992